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Corynebacterium pseudotuberculosis is the aetiological agent of caseous lymphadenitis (CLA), a
debilitating disease of sheep and goats. Accurate diagnosis of CLA primarily relies on
microbiological examination, followed by biochemical identification of isolates. In an effort to
facilitateC. pseudotuberculosis detection, a multiplex PCR (mPCR) assaywas developed targeting
three genes of this bacterium: the 16S rRNA gene, rpoB and pld. This method allowed efficient
identification of 40 isolates of this bacterium that had been identified previously by biochemical
testing. Analysis of taxonomically related species did not generate the C. pseudotuberculosis
mPCR amplification profile, thereby demonstrating the assay’s specificity. As little as 1 pg of C.
pseudotuberculosis genomic DNAwas detected by this mPCR assay, demonstrating the sensitivity
of the method. The detection limit in clinical samples was estimated to be 103 c.f.u. C.
pseudotuberculosis could be detected directly in pus samples from infected sheep and goats
(n=56) with a high diagnostic sensitivity (94.6%). The developed assay significantly improves
rapid C. pseudotuberculosis detection and could supersede bacteriological culture for
microbiological and epidemiological diagnosis of CLA.
INTRODUCTION
Corynebacterium pseudotuberculosis is a mycolic acid-
containing, facultative intracellular actinomycete associated
with the development of abscesses in a variety of
mammalian hosts (Songer et al., 1988; Peel et al., 1997;
Dorella et al., 2006). This Gram-positive bacterium most
commonly causes ulcerative lymphangitis in horses
and caseous lymphadenitis (CLA) in small ruminants
(Biberstein et al., 1971; Williamson, 2001). The latter is a
chronic disease of sheep and goats, mainly characterized by
the formation of suppurative abscesses in superficial and
internal lymph nodes (Kuria et al., 2001; Williamson, 2001).
CLA is distributed globally and causes important economic
losses for ovine and caprine husbandries, due to reduced
wool, meat and milk yields, culling of affected animals and
condemnation of carcasses and skins in slaughterhouses
(Williamson, 2001; Dorella et al., 2006).
Once established in a herd or flock, CLA eradication is
problematic due to the inefficacy of antimicrobial therapy
(Piontkowski & Shivvers, 1998; Stanford et al., 1998;
Williamson, 2001). The most reliable control strategy for
this disease involves vaccinating livestock and identifying
and removing infected animals (Brown et al., 1986; Paton
Abbreviations: CLA, caseous lymphadenitis; mPCR, multiplex PCR;
PLD, phospholipase D.
The GenBank/EMBL/DDBJ accession number for the rpoB gene
sequence of Arcanobacterium pyogenes is DQ680032.
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et al., 2003). However, this approach is hindered by
limitations in current diagnostic techniques (Williamson,
2001; Menzies et al., 2004; Dorella et al., 2006).
Many serological tests have been proposed for CLA
diagnosis, including a complement fixation test (Shigidi,
1979), synergistic haemolysis-inhibition test (Brown et al.,
1987), microagglutination assay (Menzies & Muckle, 1989)
and C. pseudotuberculosis phospholipase D (PLD) antigen-
based ELISA (Dercksen et al., 2000). Although these tests
may be of great value for the detection of subclinically
infected animals, most present drawbacks, including low
sensitivity, poor specificity and an inability to distinguish
between previously exposed animals and those still
harbouring the pathogen. Thus it is questionable whether
such techniques should be employed to orient culling
programmes (Williamson, 2001; C¸etinkaya et al., 2002).
Accurate CLA diagnosis is based primarily upon clinical
observations (external abscesses) and the identification of C.
pseudotuberculosis by phenotypic and biochemical tests; this is
important to differentiate this bacterium from other abscess-
inducing pathogenic agents, such as Arcanobacterium
pyogenes or Pasteurella multocida (Dercksen et al., 2000;
Williamson, 2001; Dorella et al., 2006).
A 16S rRNA gene-based PCR assay has been developed to
identify C. pseudotuberculosis isolates (C¸etinkaya et al.,
2002). Although this assay was useful for estimating the
prevalence of CLA in the animals studied, it presented some
limitations: (i) it was dependent on bacterial culture; and (ii)
it was not specific enough to distinguish C. pseudotubercu-
losis from Corynebacterium ulcerans (C¸etinkaya et al., 2002).
In order to improve C. pseudotuberculosis detection by PCR,
we developed a multiplex PCR (mPCR) assay and adapted a
protocol to extract bacterial genomic DNA directly from
clinical samples. Amplification of multiple loci in a single
reaction through mPCR is a powerful and widely used tool
for the rapid and specific identification of pathogenic
bacteria (Wadowsky et al., 1996; Halbert et al., 2005;
O’Halloran & Cafferkey, 2005; Persson & Olsen, 2005). Our
mPCR targeted three C. pseudotuberculosis genes: the 16S
rRNA gene, the gene of choice for most microbial taxonomy
studies (C¸etinkaya et al., 2002; Khamis et al., 2005); rpoB, the
RNA polymerase b-subunit gene, currently used to study
phylogenetic relationships in the genera Corynebacterium
andMycobacterium (Khamis et al., 2004, 2005; Dorella et al.,
2006); and pld, which encodes the exotoxin PLD, a
sphingomyelinase implicated in the virulence of C. pseudo-
tuberculosis, C. ulcerans and Arcanobacterium haemolyticum
(McNamara et al., 1995). This mPCR enabled specific
identification of C. pseudotuberculosis isolates in culture and
direct detection in pus samples from CLA-affected animals.
METHODS
Bacterial strains and culture conditions. The bacterial strains
used in this study are listed in Table 1. A total of 40 caprine isolates
of C. pseudotuberculosis were obtained from different sources. One
type strain of C. pseudotuberculosis biovar ovis (strain CIP 102968T)
and 13 strains of genetically or morphologically related bacteria were
also used in the experiments.
Bacteria were grown routinely in brain heart infusion broth (BHI;
Oxoid) or on 1.5% (w/v) BHI bacteriological agar plates at 37 uC for
48–72 h. Tween 80 was added to themedium at a final concentration of
1% (v/v) for the Corynebacterium bovis strain.
Clinical specimens. Fifty-six pus samples were collected aseptically
from abscessed lymph nodes of naturally infected sheep (n=12)
and goats (n=44) found in two CLA-endemic areas of Brazil.
Microbiological examination, followed by biochemical identification,
was used as a gold standard to confirm infection with C. pseudotu-
berculosis. In brief, bacteriological cultures were made of pus speci-
mens and the resultant C. pseudotuberculosis-resembling colonies
that stained Gram-positive were tested further for biochemical prop-
erties (glucose fermentation, urease and catalase) (Smibert &
Krieg, 1994; Dercksen et al., 2000). Synergistic haemolysis with
Rhodococcus equi ATCC 33701 and inhibition of b-haemolysis by
Staphylococcus aureus ATCC 25923 were also evaluated (Smibert &
Krieg, 1994; Dercksen et al., 2000). Species identification was con-
firmed using the API Coryne battery (bioMe´rieux).
Blood samples were taken from confirmed C. pseudotuberculosis-
infected animals (n=19) and from healthy animals (n=20) using the
Vacutainer blood collection system (Becton Dickinson).
DNA isolation
Two different protocols were adapted for extracting DNA from pure
bacterial cultures and clinical samples.
(i) Bacterial cultures. Chromosomal DNA extraction was per-
formed in the same manner for all bacterial strains. A 20 ml
48–72 h culture was centrifuged at 4 uC and 2000 g for 20 min. Cell
pellets were resuspended in 1 ml Tris/EDTA/RNase [10 mM Tris/
HCl (pH 7.0), 10 mM EDTA (pH 8.0), 300 mM NaCl, 50 mg
RNase A ml21] and centrifuged again under the same conditions.
Supernatants were discarded and the pellets were resuspended in
1 ml TE/lysozyme [25 mM Tris/HCl (pH 8.0), 10 mM EDTA
(pH 8.0), 10 mM NaCl, 10 mg lysozyme ml21). Samples were then
incubated at 37 uC for 30 min; 30 ml 30% (w/v) sodium N-lauroyl-
sarcosine (sarcosyl) was added and the mixture was incubated for
20 min at 65 uC, followed by incubation for 5 min at 4 uC. DNA was
purified using phenol/chloroform/isoamyl alcohol and precipitated
with ethanol (Sambrook et al., 1989). DNA concentrations were
determined spectrophotometrically.
(ii) Clinical samples. A DNA extraction protocol previously
described for clinical samples from tuberculosis patients (Honore´-
Bouakline et al., 2003) was adapted for use in this study. Briefly,
100 mg pus or the pellet of a 2 ml blood sample was resuspended in
1 ml TE/lysozyme. Samples were incubated for 1 h at 37 uC; 20 ml
proteinase K (20 mg ml21; Invitrogen) was added, followed by incu-
bation for 2 h at 56 uC. Samples were divided into two aliquots of
500 ml, and 25 ml 30% (w/v) sarcosyl was added to each; mixtures
were incubated for 20 min at 65 uC and then for 5 min at 4 uC.
DNA was purified and precipitated as described above.
Primers and mPCR conditions. The oligonucleotide primers
used in this study are listed in Table 2. Primers targeting the 16S
rRNA and rpoB genes of C. pseudotuberculosis were obtained from
previously published work (C¸etinkaya et al., 2002; Khamis et al.,
2004). Primers targeting the pld gene were designed by aligning the
pld nucleotide sequences of C. pseudotuberculosis and C. ulcerans
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(GenBank accession nos L16587 and L16585); the reverse primer
PLD-R1 was used in association with the forward primer PLD-F to
amplify the pld genes of both bacteria, whilst primer PLD-R2
excluded C. ulcerans (see Fig. 1b). A primer pair targeting the mito-
chondrial 12S rRNA genes of Capra hircus and Ovis aries (GenBank
accession nos AJ490504 and AJ490503) was designed to function as
an internal amplification control for the mPCRs performed with
DNA extracted directly from clinical samples of CLA. This amplifi-
cation control allowed identification of samples that possessed fac-
tors inhibitory for the mPCR assay (Hoorfar et al., 2004).
Multiplex PCRs were performed in a final reaction volume of 10 ml
containing 1.5 U AccuPrime Taq DNA polymerase (Invitrogen), 16
PCR Buffer II [200 mMTris/HCl, 500 mMKCl, 15 mMMgCl2, 2 mM
dNTPs, AccuPrime protein (Invitrogen), 10% glycerol] and 2 mM of
each of the primers 16S-F/16S-R, C2700F/C3130R and PLD-F/PLD-
R2. For mPCRs performed with DNA extracted from clinical samples,
primers 12S-F/12S-R were added to the reaction mixture at 0.2 mM
each. The template concentration was approximately 10 ng DNA
extracted from cultured C. pseudotuberculosis or from clinical speci-
mens. Where necessary, serial twofold dilutions (1 : 2, 1 : 4 and 1 : 8)
Table 1. Bacterial strains and field isolates of C. pseudotuberculosis used in this study
GUH, Ghent University Hospital, Belgium (DL and HJ: initials of donators Devrise Luc and Hommez Joseph); UFBA, Collection of Micro-
organisms of Universidade Federal da Bahia, Brazil; NCTC, National Collection of Type Cultures, UK; IOC, Collection of Micro-organisms
of Instituto Oswaldo Cruz, Brazil; CIP, Collection of the Institut Pasteur, France; ATCC, American Type Culture Collection, USA.
Species Source/strain designation
Arcanobacterium pyogenes GUH HJ 26 BA224.11
A. pyogenes-like GUH HJ 51 B
Corynebacterium amycolatum GUH HJ 08 I4218 LV
C. bovis GUH DL BOV25
C. diphtheriae ATCC 13812
C. jeikeium NCTC K411
C. pseudotuberculosis biovar equi CIP 5297
C. pseudotuberculosis biovar ovis (n=37)* VD21; VD23; VD27; VD28; VD33; VD36; VD37; VD38; VD41; VD42;
VD43; VD44; VD45; VD46; VD48; VD50; VD52; VD53; VD54; VD55;
VD56; VD57; VD58; VD59; VD60; VD61; VD62; VD63; VD99; 01; 05;
08; 09; 11; 12; 21; 217
C. pseudotuberculosis biovar ovis UFBA T1
C. pseudotuberculosis biovar ovis UFBA 1002
C. pseudotuberculosis biovar ovis GUH HJ ULCC06.334,4
C. pseudotuberculosis biovar ovis CIP 102968T
C. renale CIP 103421T
C. ulcerans GUH HJ ULCA3.675,1
C. ulcerans GUH HJ 01 BM3796.3
C. ulcerans GUH HJ 02 MN 675.3
C. ulcerans GUH HJ ULCB12.735,2
Pasteurella multocida IOC
*Caprine field isolates; obtained from Universidade Federal da Bahia, Brazil.
Table 2. List of oligonucleotide primers used in this study
Target gene Primers Sequence (5§R3§) Length of PCR products (bp) Source/reference
16S rRNA gene 16S-F ACCGCACTTTAGTGTGTGTG 816 C¸etinkaya et al. (2002)
16S-R TCTCTACGCCGATCTTGTAT
rpoB C2700F CGTATGAACATCGGCCAGGT 446 Khamis et al. (2004)
C3130R TCCATTTCGCCGAAGCGCTG
pld PLD-F ATAAGCGTAAGCAGGGAGCA 203 This work
PLD-R1 ATCAGCGGTGATTGTCTTCC
PLD-R2 ATCAGCGGTGATTGTCTTCCAGG
12S rRNA gene 12S-F CCAGCCACCGCGGTCATACG 274 This work
12S-R TGAGTTTCGGGCTGTTGCCG
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were performed on samples to dilute inhibitory components (Honore´-
Bouakline et al., 2003). Reactions were carried out in a thermal cycler
(PTC-100; MJ Research) under the following conditions: initial
denaturation at 95 uC for 3 min; 40 cycles of 95 uC for 1 min, 58 uC for
40 s and 68 uC for 1 min 30 s; final extension at 68 uC for 7 min. The
amplified products were resolved by electrophoresis on 1.0% (w/v)
agarose gels and visualized by ethidium bromide staining.
Sequencing of singleplex PCR products. In order to confirm
the mPCR results, ten randomly chosen isolates were tested further
in singleplex PCR assays with the three C. pseudotuberculosis-specific
primer pairs. PCR products were precipitated with 15% (w/v) poly-
ethylene glycol (Kusukawa et al., 1990) and sequenced using the
DYEnamic ET Dye Terminator kit (Amersham Biosciences), accord-
ing to the manufacturer’s instructions. The sequences were com-
pared with previously published 16S rRNA (GenBank accession nos
X81916, X81907 and X84255), rpoB (GenBank accession no.
AY492239) and pld (GenBank accession nos L16586 and L16587) C.
pseudotuberculosis gene sequences, by searching for similarity using
BLAST-N (Altschul et al., 1990).
Analytical specificity and sensitivity. To evaluate the specificity
of the mPCR assay, reactions were performed with genomic DNA
extracted from bacterial strains taxonomically similar to C. pseudotu-
berculosis biovar ovis (Table 1). Serial tenfold dilutions of DNA from
C. pseudotuberculosis type strain CIP 102968T, ranging from 10 to
0.0001 ng DNA per reaction, were used to test the sensitivity of the
method.
To evaluate the assay’s detection limit, blood samples from goats that
did not present clinical symptoms of CLA, and which were negative in
ELISA tests (performed according to Paule et al., 2003), were seeded
with 101–106 c.f.u. of C. pseudotuberculosis.
Statistical analysis. An analysis to evaluate differences in the sen-
sitivity of the mPCR assay between samples from sheep versus goats
was performed with a x2 test, using the STATISTICA software package
(StatSoft).
RESULTS
Specificity and sensitivity of the mPCR assay
Purified genomic DNAs were used to evaluate the sensitivity
and specificity of the mPCR assay. When tested with DNA
from bacterial strains taxonomically related to C. pseudo-
tuberculosis biovar ovis (Table 1), only C. pseudotuberculosis
biovar equi CIP 5297 yielded a similar mPCR profile, with
the 816, 446 and 203 bp amplicons corresponding to the 16S
rRNA, rpoB and pld genes, respectively (Fig. 1a). As in a
previous study (Khamis et al., 2004), all of the corynebac-
teria species that we tested generated an amplicon of
~446 bp, corresponding to the rpoB gene (Fig. 1a). As
expected, the pld gene product was not detected in any of the
four C. ulcerans strains (Fig. 1a, lanes 4–7), illustrating the
ability of the mPCR assay to differentiate this bacterium
from C. pseudotuberculosis. Moreover, two other pathogenic
bacteria associated with the formation of abscesses in small
ruminants, A. pyogenes and P. multocida, were clearly
distinguished (Fig. 1a). The~300 bp product generated by
amplification of A. pyogenes genomic DNA was sequenced
and assigned as the rpoB gene following a search for
homology in GenBank using BLAST-N (data not shown).
To determine the sensitivity of the assay, reactions were
performed with serial tenfold dilutions of purified C.
pseudotuberculosis CIP 102968T DNA. The mPCR method
Fig. 1. Analytical specificity of the mPCR assay. (a) Amplification
profiles of bacteria genetically or morphologically related to C.
pseudotuberculosis. Lanes 1–15 show reactions with DNA from
the following bacterial strains: 1 and 2, C. pseudotuberculosis
ovis strains CIP 102968T and 1002; 3, C. pseudotuberculosis
equi CIP 5297; 4–7, C. ulcerans strains ULCA3.675,1, HJ 01
BM3796.3, HJ 02 MN 675.3 and ULCB12.735,2; 8, C. diphther-
iae ATCC 13812; 9, Corynebacterium amycolatum HJ 08 I4218
LV; 10, Corynebacterium renale CIP 103421T; 11, C. bovis DL
BOV25; 12, Corynebacterium jeikeium K411; 13, Arcano-
bacterium pyogenes HJ 26 BA224.11; 14, A. pyogenes-like HJ 51
B; 15, Pasteurella multocida. Lane 16, negative control (reaction
without template DNA). MW, 1 kb Plus DNA Ladder (Invitrogen).
(b) Schematic representation of primer-annealing sites in the pld
genes of C. pseudotuberculosis (Cp) and C. ulcerans (Cu). The
underlined nucleotides indicate positions of mismatch between
the two aligned gene sequences (see text for details).
Fig. 2. Analytical sensitivity of the mPCR assay. Lanes 1–6,
mPCR with serial tenfold dilutions of C. pseudotuberculosis
CIP 102968T genomic DNA, as follows: 10, 1, 0.1, 0.01,
0.001 and 0.0001 ng. Lane 7, negative control (reaction with-
out template DNA). MW, 1 kb Plus DNA Ladder (Invitrogen).
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was able to detect bacterial DNA at concentrations ranging
from 10 to 0.001 ng per reaction (Fig. 2).
To assess the detection limit of the assay in clinical
specimens, blood samples of healthy animals were spiked
with tenfold dilutions of a pure culture of C. pseudotu-
berculosis CIP 102968T and the mixtures were processed
using the entire DNA extraction protocol. Amplification
products were detected in reactions containing 103–106 c.f.u.
C. pseudotuberculosis (ml sample)21 (data not shown).
Identification of bacterial isolates
The characteristic mPCR amplification profile was obtained
for all 40 C. pseudotuberculosis biovar ovis field isolates
tested (Table 1). Fig. 3(a) shows the mPCR profiles of ten
randomly chosen C. pseudotuberculosis biovar ovis field
isolates.
Identification of the ten isolates was confirmed by
sequencing each of the three amplicons generated, followed
by a search for similar sequences using BLAST-N (data not
shown).
Direct detection of C. pseudotuberculosis in
clinical samples by mPCR
Pus samples were collected from the lymph nodes of CLA-
affected sheep and goats and DNA was extracted directly
from these specimens using our protocol (see Methods). A
bacteriological culture was prepared from the samples as a
gold standard to confirm infection by C. pseudotuberculosis.
The mPCR protocol was performed as described for purified
bacterial DNA; however, a non-competitive internal
amplification control (12S rDNA; see Methods) was
included in these reactions in order to allow differentiation
between inhibited reactions, i.e. those in which there was no
amplification of the internal control, and reactions in which
the mPCR yielded a negative result (Hoorfar et al., 2004).
Typical mPCR profiles of clinical samples are shown in
Fig. 3(b).
Most of the undiluted samples were inhibitory for themPCR
assay, but more than 52% yielded detectable results at a 1 : 2
dilution and~45% showed amplification at a 1 : 4 dilution,
whilst only 3% showed amplification at a 1 : 8 dilution. The
proportions of samples positive in the mPCR assay were not
significantly different when comparing samples of sheep
versus goats (P=0.60). Table 3 summarizes the results
obtained for pus samples.
The ability of the mPCR assay to detect C. pseudotuberculosis
in blood samples from confirmed CLA-affected animals was
also evaluated; however, none of the 19 blood samples that
we tested yielded a positive result (data not shown).
DISCUSSION
CLA remains a cause of concern for sheep and goat
producers worldwide (Baird, 1997;Williamson, 2001; Paton
et al., 2003; Dorella et al., 2006). Due to the high
transmission rate of its aetiological agent, C. pseudotuber-
culosis, within a herd or flock, some authors suggest the
culling of any animal from which this bacterium has been
cultured as a means of controlling spread of the disease
(Baird, 1997; Williamson, 2001). As microbiological and
biochemical methods are not always straightforward, the
development of a rapid and specific diagnostic tool is
imperative for the control of CLA (C¸etinkaya et al., 2002).
The only previously reported molecular method employed
for specific identification of C. pseudotuberculosis isolated
from pus samples of CLA-affected animals, based on the
amplification of a 16S rRNA gene fragment (C¸etinkaya et al.,
2002), has two major drawbacks: (i) dependence on
bacterial culture; and (ii) an inability to distinguish the
bacterium C. ulcerans.
Fig. 3. Reproducibility of the mPCR assay. (a) Lanes 1–10,
mPCR amplification profiles of 10 of the 40 field isolates of C.
pseudotuberculosis. MW, GeneRuler DNA Ladder Mix
(Fermentas). (b) Lanes 1–3, direct detection of C. pseudotu-
berculosis in pus samples of CLA-affected animals. MW, 1 kb
Plus DNA Ladder (Invitrogen).
Table 3. Results of direct detection of C. pseudotuberculo-
sis in pus samples of CLA-affected animals using the
mPCR assay
Pus samples* mPCR result Sensitivity (%)
Positive Negative
Sheep (n=12) 11 1 91.7
Goats (n=44) 42 2 95.4
Total (n=56) 53 3 94.6
*Samples positive for C. pseudotuberculosis in bacteriological culture
(gold standard).
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Our mPCR assay was specific enough to differentiate C.
pseudotuberculosis from C. ulcerans (Fig. 1a). These two
bacteria have been reported to possess 99.7% similarity
between their 16S rRNA genes and 93.6% between their rpoB
genes (Riegel et al., 1995; Khamis et al., 2004); most of their
biochemical properties are similar and both may eventually
produce diphtheric toxin (Riegel et al., 1995; DeWinter et al.,
2005). The high genomic similarity may explain the inability
of a previously published study to differentiate these two
bacteria by PCR (C¸etinkaya et al., 2002). As C. ulcerans is also
a PLD producer, the reverse primer used to amplify the pld
gene in our study was designed so that it possessed a
mismatch in its 39 end (two Gs instead of two Cs) (Fig. 1b),
allowing differentiation from C. pseudotuberculosis due to the
absence of the 203 bp amplicon.
Although C. ulcerans is primarily recognized as a veterinary
pathogen, there has been a marked increase in the number of
human infections (DeWinter et al., 2005; De Zoysa et al.,
2005) and it appears that domestic cats and dogs can be
potential reservoirs (DeZoysa et al., 2005). In this context, our
mPCR would be able to identify bacteria collected from the
nasal discharge of domestic animals and could differentiate
bacteria cultured from samples from diphtheria patients by
using the primer pair PLD-F/PLD-R1, which allows ampli-
fication of the pld gene of C. ulcerans (see Fig. 1b).
C¸etinkaya et al. (2002) reported a weaker amplification of
the 816 bp 16S rRNA gene amplicon in biovar equi of C.
pseudotuberculosis when compared with that of biovar ovis.
This result was attributed to a mismatch (an A instead of a
G) five bases from the 59 end of the forward primer used
(16S-F; Table 2). However, this result was not reproducible
under the conditions used in our study. We propose that
amplification of the 16S rRNA gene using primers 16S-F/
16S-R is not sufficient to differentiate the two biovars of C.
pseudotuberculosis. It is interesting that infection of small
ruminants with biovar equi is not known to occur (Spier
et al., 2004).
The mPCR assay was able to confirm the identification of 40
C. pseudotuberculosis field isolates and reliably detected this
bacterium in a reaction mixture containing as little as
0.001 ng of genomic DNA, illustrating its reproducibility
and high sensitivity.
A DNA extraction protocol was adapted to recover bacterial
genomic DNA directly from clinical samples of CLA-affected
animals. This strategy offers advantages over bacteriological
culture, including reduced time of analysis and the ability to
detect unviable bacteria. The detection limit of the goat
blood spiking experiment was 103 c.f.u.C. pseudotuberculosis
(ml sample)21. However, this value may underestimate the
number of viable organisms, as intracellular bacteria such as
C. pseudotuberculosis and R. equi have a tendency to clump
when cultured (Harrington et al., 2005). A detection limit
above 103 c.f.u. (ml sample)21 would help explain the
inability of the mPCR assay to detect C. pseudotuberculosis in
blood samples from infected sheep and goats.
On the other hand, the mPCR efficiently detected this
bacterium in a high proportion (94.6%) of confirmed CLA-
infected pus samples. In contrast to serological CLA testing
(Menzies & Muckle, 1989; Dercksen et al., 2000), the mPCR
sensitivity was the same for both sheep and goats (Table 3).
As ourmPCR assay provides an efficient, accurate, rapid and
reproducible method for the identification of cultured C.
pseudotuberculosis and its direct detection in pus samples, we
propose that it may be used instead of bacteriological culture
as a confirmatory CLA test.
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